We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Omniscient Neurotechnology Stock

Invest in or calculate the value of your shares in Omniscient Neurotechnology or other pre-IPO companies through EquityZen's platform.

Get Started

Omniscient Neurotechnology Stock (OMNE)

Omniscient develops AI and data-driven solutions to improve treatment for brain disorders, providing predictive analytics for clinicians.

About Omniscient Neurotechnology Stock

Founded

2019

Industries

Software, Artificial Intelligence, Data and Analytics

Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.

Omniscient Neurotechnology Management

Leadership team at Omniscient Neurotechnology

Chief Medical Officer & Director

Michael Sughrue

Chief Data Scientist & Director

Stephane Doyen

Locked Features

Join now and verify your accreditation status to gain access to:

  • Omniscient Neurotechnology current valuation
  • Omniscient Neurotechnology stock price
  • Available deals in Omniscient Neurotechnology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Omniscient Neurotechnology stock?

Accredited investors can buy pre-IPO stock in companies like Omniscient Neurotechnology through EquityZen funds. These investments are made available by existing Omniscient Neurotechnology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Omniscient Neurotechnology stock?

Shareholders can sell their Omniscient Neurotechnology stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."